UK RRT Incidence in 2009: national and centre-specific analyses

C. Castledine, T. Feest, Damian Fogarty, R. Steenkamp, C. Castledine

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

19 Citations (Scopus)

Abstract

Introduction: This chapter describes the characteristics of
adult patients on renal replacement therapy (RRT) in the
UK in 2009. The prevalence rates per million population
(pmp) were calculated for Primary Care Trusts in England,
Health and Social Care Areas in Northern Ireland, Local
Health Boards in Wales and Health Boards in Scotland.
These areas will be referred to in this report as ‘PCT/HBs’.
Methods: Data were electronically collected from all 72
renal centres within the UK. A series of cross-sectional and
longitudinal analyses were performed to describe the
demographics of prevalent RRT patients in 2009 at centre
and national level. Age and gender standardised ratios for
prevalence rates in PCT/HBs were calculated. Results:
There were 49,080 adult patients receiving RRT in the UK
on 31st December 2009, equating to a UK prevalence of
794 pmp. This represented an annual increase in prevalent
numbers of approximately 3.2% although there was significant
variation between centres and PCT/HB areas. The
growth rate from 2008 to 2009 for prevalent patients by
treatment modality in the UK was 4.2% for haemodialysis
(HD), a fall of 7.2% for peritoneal dialysis (PD) and a
growth of 4.4% with a functioning transplant. There has
been a slow but steady decline in the proportion of PD
patients from 2000 onwards. Median RRT vintage was 5.4
years. The median age of prevalent patients was 57.7
years (HD 65.9 years, PD 61.2 years and transplant 50.8
years). For all ages, prevalence rates in males exceeded
those in females: peaks for males were in the 75–79 years
age group at 2,632 pmp and for females in the 70–74
years age group at 1,445 pmp. The most common identifiable
renal diagnosis was biopsy-proven glomerulonephritis
(16.0%), followed by diabetes (14.7%). Transplantation was
the most common treatment modality (48%), HD in 44%
and PD 8%. However, HD was increasingly common with
increasing age and transplantation less common. Conclusions:
The HD and transplant population continued to
expand whilst the PD population contracted. There were
national, regional and dialysis centre level variations in
prevalence rates. This has implications for service planning
and ensuring equity of care for RRT patients.
Original languageEnglish
Title of host publicationUK Renal Registry 13th Annual Report (December 2010)
PublisherKarger
Pagesc27–c52
Volume119(suppl 2)
DOIs
Publication statusAccepted - 2011

Publication series

NameNephron Clinical Practice
PublisherKarger
Volume119
ISSN (Electronic)1660-2110

Fingerprint

Renal Replacement Therapy
Renal Dialysis
Peritoneal Dialysis
Incidence
Population
Transplants
Transplantation
Northern Ireland
Wales
Scotland
Glomerulonephritis
England
Dialysis
Primary Health Care
Age Groups
Cross-Sectional Studies
Delivery of Health Care
Biopsy
Health

Cite this

Castledine, C., Feest, T., Fogarty, D., Steenkamp, R., & Castledine, C. (Accepted/In press). UK RRT Incidence in 2009: national and centre-specific analyses. In UK Renal Registry 13th Annual Report (December 2010) (Vol. 119(suppl 2), pp. c27–c52). (Nephron Clinical Practice; Vol. 119). Karger. https://doi.org/10.1159/000331744
Castledine, C. ; Feest, T. ; Fogarty, Damian ; Steenkamp, R. ; Castledine, C. / UK RRT Incidence in 2009: national and centre-specific analyses. UK Renal Registry 13th Annual Report (December 2010). Vol. 119(suppl 2) Karger, 2011. pp. c27–c52 (Nephron Clinical Practice).
@inbook{e17828a175174f38980ac1912dfa959d,
title = "UK RRT Incidence in 2009: national and centre-specific analyses",
abstract = "Introduction: This chapter describes the characteristics ofadult patients on renal replacement therapy (RRT) in theUK in 2009. The prevalence rates per million population(pmp) were calculated for Primary Care Trusts in England,Health and Social Care Areas in Northern Ireland, LocalHealth Boards in Wales and Health Boards in Scotland.These areas will be referred to in this report as ‘PCT/HBs’.Methods: Data were electronically collected from all 72renal centres within the UK. A series of cross-sectional andlongitudinal analyses were performed to describe thedemographics of prevalent RRT patients in 2009 at centreand national level. Age and gender standardised ratios forprevalence rates in PCT/HBs were calculated. Results:There were 49,080 adult patients receiving RRT in the UKon 31st December 2009, equating to a UK prevalence of794 pmp. This represented an annual increase in prevalentnumbers of approximately 3.2{\%} although there was significantvariation between centres and PCT/HB areas. Thegrowth rate from 2008 to 2009 for prevalent patients bytreatment modality in the UK was 4.2{\%} for haemodialysis(HD), a fall of 7.2{\%} for peritoneal dialysis (PD) and agrowth of 4.4{\%} with a functioning transplant. There hasbeen a slow but steady decline in the proportion of PDpatients from 2000 onwards. Median RRT vintage was 5.4years. The median age of prevalent patients was 57.7years (HD 65.9 years, PD 61.2 years and transplant 50.8years). For all ages, prevalence rates in males exceededthose in females: peaks for males were in the 75–79 yearsage group at 2,632 pmp and for females in the 70–74years age group at 1,445 pmp. The most common identifiablerenal diagnosis was biopsy-proven glomerulonephritis(16.0{\%}), followed by diabetes (14.7{\%}). Transplantation wasthe most common treatment modality (48{\%}), HD in 44{\%}and PD 8{\%}. However, HD was increasingly common withincreasing age and transplantation less common. Conclusions:The HD and transplant population continued toexpand whilst the PD population contracted. There werenational, regional and dialysis centre level variations inprevalence rates. This has implications for service planningand ensuring equity of care for RRT patients.",
author = "C. Castledine and T. Feest and Damian Fogarty and R. Steenkamp and C. Castledine",
year = "2011",
doi = "10.1159/000331744",
language = "English",
volume = "119(suppl 2)",
series = "Nephron Clinical Practice",
publisher = "Karger",
pages = "c27–c52",
booktitle = "UK Renal Registry 13th Annual Report (December 2010)",

}

Castledine, C, Feest, T, Fogarty, D, Steenkamp, R & Castledine, C 2011, UK RRT Incidence in 2009: national and centre-specific analyses. in UK Renal Registry 13th Annual Report (December 2010). vol. 119(suppl 2), Nephron Clinical Practice, vol. 119, Karger, pp. c27–c52. https://doi.org/10.1159/000331744

UK RRT Incidence in 2009: national and centre-specific analyses. / Castledine, C.; Feest, T.; Fogarty, Damian; Steenkamp, R.; Castledine, C.

UK Renal Registry 13th Annual Report (December 2010). Vol. 119(suppl 2) Karger, 2011. p. c27–c52 (Nephron Clinical Practice; Vol. 119).

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)

TY - CHAP

T1 - UK RRT Incidence in 2009: national and centre-specific analyses

AU - Castledine, C.

AU - Feest, T.

AU - Fogarty, Damian

AU - Steenkamp, R.

AU - Castledine, C.

PY - 2011

Y1 - 2011

N2 - Introduction: This chapter describes the characteristics ofadult patients on renal replacement therapy (RRT) in theUK in 2009. The prevalence rates per million population(pmp) were calculated for Primary Care Trusts in England,Health and Social Care Areas in Northern Ireland, LocalHealth Boards in Wales and Health Boards in Scotland.These areas will be referred to in this report as ‘PCT/HBs’.Methods: Data were electronically collected from all 72renal centres within the UK. A series of cross-sectional andlongitudinal analyses were performed to describe thedemographics of prevalent RRT patients in 2009 at centreand national level. Age and gender standardised ratios forprevalence rates in PCT/HBs were calculated. Results:There were 49,080 adult patients receiving RRT in the UKon 31st December 2009, equating to a UK prevalence of794 pmp. This represented an annual increase in prevalentnumbers of approximately 3.2% although there was significantvariation between centres and PCT/HB areas. Thegrowth rate from 2008 to 2009 for prevalent patients bytreatment modality in the UK was 4.2% for haemodialysis(HD), a fall of 7.2% for peritoneal dialysis (PD) and agrowth of 4.4% with a functioning transplant. There hasbeen a slow but steady decline in the proportion of PDpatients from 2000 onwards. Median RRT vintage was 5.4years. The median age of prevalent patients was 57.7years (HD 65.9 years, PD 61.2 years and transplant 50.8years). For all ages, prevalence rates in males exceededthose in females: peaks for males were in the 75–79 yearsage group at 2,632 pmp and for females in the 70–74years age group at 1,445 pmp. The most common identifiablerenal diagnosis was biopsy-proven glomerulonephritis(16.0%), followed by diabetes (14.7%). Transplantation wasthe most common treatment modality (48%), HD in 44%and PD 8%. However, HD was increasingly common withincreasing age and transplantation less common. Conclusions:The HD and transplant population continued toexpand whilst the PD population contracted. There werenational, regional and dialysis centre level variations inprevalence rates. This has implications for service planningand ensuring equity of care for RRT patients.

AB - Introduction: This chapter describes the characteristics ofadult patients on renal replacement therapy (RRT) in theUK in 2009. The prevalence rates per million population(pmp) were calculated for Primary Care Trusts in England,Health and Social Care Areas in Northern Ireland, LocalHealth Boards in Wales and Health Boards in Scotland.These areas will be referred to in this report as ‘PCT/HBs’.Methods: Data were electronically collected from all 72renal centres within the UK. A series of cross-sectional andlongitudinal analyses were performed to describe thedemographics of prevalent RRT patients in 2009 at centreand national level. Age and gender standardised ratios forprevalence rates in PCT/HBs were calculated. Results:There were 49,080 adult patients receiving RRT in the UKon 31st December 2009, equating to a UK prevalence of794 pmp. This represented an annual increase in prevalentnumbers of approximately 3.2% although there was significantvariation between centres and PCT/HB areas. Thegrowth rate from 2008 to 2009 for prevalent patients bytreatment modality in the UK was 4.2% for haemodialysis(HD), a fall of 7.2% for peritoneal dialysis (PD) and agrowth of 4.4% with a functioning transplant. There hasbeen a slow but steady decline in the proportion of PDpatients from 2000 onwards. Median RRT vintage was 5.4years. The median age of prevalent patients was 57.7years (HD 65.9 years, PD 61.2 years and transplant 50.8years). For all ages, prevalence rates in males exceededthose in females: peaks for males were in the 75–79 yearsage group at 2,632 pmp and for females in the 70–74years age group at 1,445 pmp. The most common identifiablerenal diagnosis was biopsy-proven glomerulonephritis(16.0%), followed by diabetes (14.7%). Transplantation wasthe most common treatment modality (48%), HD in 44%and PD 8%. However, HD was increasingly common withincreasing age and transplantation less common. Conclusions:The HD and transplant population continued toexpand whilst the PD population contracted. There werenational, regional and dialysis centre level variations inprevalence rates. This has implications for service planningand ensuring equity of care for RRT patients.

U2 - 10.1159/000331744

DO - 10.1159/000331744

M3 - Chapter (peer-reviewed)

VL - 119(suppl 2)

T3 - Nephron Clinical Practice

SP - c27–c52

BT - UK Renal Registry 13th Annual Report (December 2010)

PB - Karger

ER -

Castledine C, Feest T, Fogarty D, Steenkamp R, Castledine C. UK RRT Incidence in 2009: national and centre-specific analyses. In UK Renal Registry 13th Annual Report (December 2010). Vol. 119(suppl 2). Karger. 2011. p. c27–c52. (Nephron Clinical Practice). https://doi.org/10.1159/000331744